Repurposing and repositioning have gained considerable attention from a range of stakeholders, including NIH, academic institutions, pharmaceutical companies, and even some technology companies, for ...

SDG 3 - Good health and wellbeing. This Scientific Reports Collection welcomes original research on Drug repurposing and repositioning efforts. Narrative review articles are also welcomed, to our ...

When it comes to drug repurposing, companies may be searching for a systematic approach to serendipity. The emphasis, however, still seems to be on the serendipity part of the equation. In this regard ...

Before a drug can be used to treat a disease, it must go through a lengthy and expensive trial process to prove both safety and effectiveness. By repurposing already-approved drugs, researchers can ...

London, July 1, 2024: The Drug Repurposing & Repositioning Inventions Boardroom provided a deep dive on this important topic with industry experts from NLO, 3D-PharmXchange, and the Repo4EU consortium ...

More than six million Americans are living with Alzheimer’s disease (AD), the leading cause of dementia worldwide, and nearly 95 percent of all AD cases are late-onset. However, the current success ...

Endometriosis, a chronic inflammatory disease that affects approximately one in ten women of reproductive age—around 190 million worldwide—remains poorly understood from a biological perspective, ...

This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...